1. Home
  2. BATL vs FBLG Comparison

BATL vs FBLG Comparison

Compare BATL & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BATL
  • FBLG
  • Stock Information
  • Founded
  • BATL 1987
  • FBLG 2021
  • Country
  • BATL United States
  • FBLG United States
  • Employees
  • BATL N/A
  • FBLG N/A
  • Industry
  • BATL Oil & Gas Production
  • FBLG
  • Sector
  • BATL Energy
  • FBLG
  • Exchange
  • BATL Nasdaq
  • FBLG NYSE
  • Market Cap
  • BATL 40.0M
  • FBLG 37.1M
  • IPO Year
  • BATL N/A
  • FBLG 2024
  • Fundamental
  • Price
  • BATL $1.35
  • FBLG $0.61
  • Analyst Decision
  • BATL
  • FBLG Strong Buy
  • Analyst Count
  • BATL 0
  • FBLG 4
  • Target Price
  • BATL N/A
  • FBLG $13.00
  • AVG Volume (30 Days)
  • BATL 3.1M
  • FBLG 501.8K
  • Earning Date
  • BATL 08-13-2025
  • FBLG 08-06-2025
  • Dividend Yield
  • BATL N/A
  • FBLG N/A
  • EPS Growth
  • BATL N/A
  • FBLG N/A
  • EPS
  • BATL N/A
  • FBLG N/A
  • Revenue
  • BATL $191,498,000.00
  • FBLG N/A
  • Revenue This Year
  • BATL N/A
  • FBLG N/A
  • Revenue Next Year
  • BATL N/A
  • FBLG N/A
  • P/E Ratio
  • BATL N/A
  • FBLG N/A
  • Revenue Growth
  • BATL N/A
  • FBLG N/A
  • 52 Week Low
  • BATL $1.05
  • FBLG $0.59
  • 52 Week High
  • BATL $6.89
  • FBLG $5.62
  • Technical
  • Relative Strength Index (RSI)
  • BATL 43.09
  • FBLG 31.83
  • Support Level
  • BATL $1.21
  • FBLG $0.62
  • Resistance Level
  • BATL $3.21
  • FBLG $0.75
  • Average True Range (ATR)
  • BATL 0.46
  • FBLG 0.06
  • MACD
  • BATL -0.10
  • FBLG -0.01
  • Stochastic Oscillator
  • BATL 5.69
  • FBLG 5.35

About BATL Battalion Oil Corporation

Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.

About FBLG FIBROBIOLOGICS INC

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Share on Social Networks: